Curated News: Medical Meetings

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

The University of Texas MD Anderson Cancer Center will host its virtual Leading Edge of Cancer Research Symposium from November 17-18, 2022, featuring presentations and discussions on important topics in discovery and translational research that will drive the next wave of cancer breakthroughs. The event also includes a virtual poster session; interested researchers are encouraged to submit abstracts by October 24, 2022.

• share
• favorite_border

Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial found that over-the-counter aspirin is just as effective.

• share
• favorite_border

The Glaucoma Seminar 2022, The Future is Now: Translating New Information into Clinical Practice, will provide a unique opportunity for eyecare professionals and others to explore the future of glaucoma diagnosis and treatment.

• share
• favorite_border

E. Christopher Ellison, MD, FACS, an esteemed general surgeon from Columbus, Ohio, will be installed for a one-year term as the 103rd President of the American College of Surgeons.

• share
• favorite_border

Cedars-Sinai Orthopaedic Trauma experts will present their latest advances in treatments and research at the annual meeting of the Orthopaedic Trauma Association (OTA) in Florida Oct. 12-15.

• share
• favorite_border

Julie O’Sullivan Maillet, a nationally recognized leader in clinical nutrition education and practice, has been named the 2022 recipient of the Lifetime Achievement Award, the highest honor given by the Academy of Nutrition and Dietetics, the world’s largest organization of food and nutrition professionals.

• share
• favorite_border

The Desai Sethi Urology Institute at the University of Miami Miller School of Medicine will be hosting urology clinicians and scientists from today’s most prominent academic centers at the institute’s inaugural in-person "Urology on the Beach" meeting, January 13 to 15, 2023, at the Fontainebleau Hotel in Miami Beach.

• share
• favorite_border

The American Society for Radiation Oncology (ASTRO) announced today the 10 studies that will be highlighted in the 2022 ASTRO Annual Meeting press program. Researchers will discuss their findings in two news briefings to be held October 24 and 25 in the Henry B. Gonzalez Convention Center in San Antonio and via live webcast. Reporters can register for the meeting at astro.org/annualmeetingpress.

• share
• favorite_border

ISPOR Europe 2022 plenaries and speakers have been announced for the 6-9 November conference in Vienna, Austria.

• share
• favorite_border

Cleveland: Findings from a Cleveland Clinic-led trial show that increasing the salt intake by mouth for patients who are hospitalized with heart failure undergoing aggressive diuretic therapy did not affect how much fluid they retain or their kidney function, indicating that salt intake for heart failure patients may not be as harmful as previously thought. Conversely, these new findings may challenge the common practice of salt restriction during hospital admission since that might not be as helpful.

• share
• favorite_border

New data validate the benefits of the BVA-100 diagnostic blood volume measurement test in reducing hospital length of stay (LOS) for heart failure (HF) patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world’s leading experts in heart failure.

• share
• favorite_border

New data validate the benefits of the BVA-100 blood volume measurement test for Medicare heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world’s leading experts in heart failure.

• share
• favorite_border

A new AMD drug has shown it can slow the progression of this devastating eye condition.

• share
• favorite_border

Researchers used data from the IRIS Registry to get a cross-sectional view of childhood blindness in the US.

• share
• favorite_border

Researchers found that people who consumed high amounts of vitamins A, C, and E, either as supplements or through food, were 47 percent less likely to develop glaucoma.

• share
• favorite_border

A large, nationwide study from Taiwan shows that people with normal-tension glaucoma are at high risk for developing Alzheimer’s disease.

• share
• favorite_border

The IRIS® Registry (Intelligent Research in Sight) powered several big data studies this year, most of which will be presented and discussed at AAO 2022 Gather.

• share
• favorite_border

The number of people with wet age-related macular degeneration (AMD) who fail to show up for follow-up appointments is higher than ophthalmologists feared.

• share
• favorite_border

Researchers found that children who were more physically fit were less likely to develop allergic conjunctivitis.

• share
• favorite_border

Nutrition and health experts from around the world will explore the latest advances in medical nutrition therapy, health care technology and access to nutrition services at the Academy of Nutrition and Dietetics’ 2022 Food & Nutrition Conference & Expo®, October 8 to 11, at the Orlando Convention Center in Orlando, Fla.

• share
• favorite_border

The 2022 NCCN Annual Congress on Hematologic Malignancies™ (#NCCNhem22) is taking place Friday, October 14–Saturday, October 15, 2022 in New York City. All live sessions will also stream remotely through a virtual event platform.

• share
• favorite_border

The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2022, the ACR’s annual meeting taking place Nov. 10 – 14.

• share
• favorite_border

The Academy of Nutrition and Dietetics will host the 2022 Food & Nutrition Conference & ExpoTM October 8 to 11 at the Orange County Convention Center in Orlando, Fla.

• share
• favorite_border

Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral regurgitation (DMR) found that the PASCAL transcatheter valve repair system was non-inferior compared with MitraClip in patients with significant symptomatic DMR who are not eligible for mitral valve surgery. Findings from the CLASP IID trial were reported today at TCT 2022, the 34th annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.

• share
• favorite_border

An analysis from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) TVT Registry found that most patients with severe mitral regurgitation (MR) and cardiogenic shock (CS) who underwent mitral transcatheter edge-to-edge repair (TEER) in the United States achieved successful MR reduction, and that successful repair was associated with lower mortality and heart failure (HF) hospitalizations at one year post-procedure compared with unsuccessful repair.

• share
• favorite_border

Mount Sinai Heart leader will be recognized for his exceptional career achievements at the 34th annual conference.

• share
• favorite_border

Según los investigadores de Mayo Clinic, las mujeres con antecedentes de preeclampsia grave tienen más indicadores de un mayor riesgo de sufrir daño e inflamación en las células del cerebro en comparación con aquellas que tuvieron embarazos sin complicaciones.

• share
• favorite_border

Pesquisadores da Mayo Clinic descobriram que mulheres com histórico de pré-eclâmpsia grave têm mais indicadores de maior risco de danos e inflamação das células cerebrais em comparação com mulheres que tiveram gestações sem complicações.

• share
• favorite_border

Newly released results from the Phase III ADAURA trial reveal that osimertinib yielded a 5.5-year median disease-free survival in the post-surgical treatment of patients with EGFR-mutated lung cancer, and nearly three in four patients treated with adjuvant osimertinib were disease-free at four years. The new results also indicated that the use of osimertinib reduced the risk of disease recurrence in the brain and spinal cord.

• share
• favorite_border

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in patients with refractory metastatic colorectal cancer. Findings from the global FRESCO-2 trial were presented today at the European Society for Medical Oncology (ESMO) Congress 2022.

• share
• favorite_border

Patients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer reported that the treatment maintained their quality of life (QoL) compared to conventional chemotherapy, according to results presented today by researchers from The University of Texas MD Anderson Cancer Center at the European Society for Medical Oncology (ESMO) Congress 2022.

• share
• favorite_border

Physicians and scientists from Cedars-Sinai will be attending and sharing research and clinical breakthroughs at the American Rhinologic Society Annual Meeting (ARS) taking place Sept. 9-10, the American Neurotology Society (ANS) “Super Saturday” Meeting Sept. 10, and the American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting (AAO-HNSF22) taking place Sept. 10-14, in Philadelphia.

• share
• favorite_border

A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist from Dana-Farber Cancer Institute.

• share
• favorite_border

Among several lifestyle changes that may reduce cardiovascular disease, adopting the DASH (Dietary Approaches to Stop Hypertension) diet may have the greatest impact for young and middle-aged adults with stage 1 hypertension, according to new research presented at the American Heart Association’s Hypertension Scientific Sessions 2022, held Sept. 7-10, 2022, in San Diego.

• share
• favorite_border

Combination therapies show encouraging results in several studies led by Dana-Farber Cancer Institute and presented for the first time at the European Society of Medical Oncology (ESMO) Congress 2022, Paris, France. The studies will be presented both in-person and online on September 9-13, 2022.

• share
• favorite_border

In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.

• share
• favorite_border

Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR

• share
• favorite_border

Tattoo inks are unregulated in the U.S. A team has analyzed what is in some inks, and it doesn’t always match what’s on ingredient labels. Once the study is complete, they will publish their results on a website for consumers and tattoo artists. They will present their results at ACS Fall 2022.